Adjusting fat production in the eye to treat diabetic eye disease
Modulating retinal lipid biogenesis in diabetes for therapeutic effects
This project explores how changes in fat production in the eye during diabetes contribute to vision loss, hoping to find new treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11133035 on NIH RePORTER |
What this research studies
Diabetic retinopathy is a common cause of vision loss in adults, and current treatments are not always enough to prevent it. This project looks at early changes in how the retina, the light-sensing part of the eye, uses energy when someone has diabetes. Researchers discovered that in diabetes, the retina starts making significantly more fats, specifically a fat called palmitate. By understanding and targeting these early metabolic shifts, the goal is to develop new and more effective therapies to protect vision.
Who could benefit from this research
Good fit: This research is relevant for adults living with diabetes who are at risk of or experiencing vision problems due to diabetic retinopathy.
Not a fit: Patients whose vision loss is not related to diabetic retinopathy may not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that prevent or slow down vision loss for people with diabetic retinopathy.
How similar studies have performed: This approach explores a newly discovered metabolic shift in the retina during diabetes, representing a novel direction for therapeutic development.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Rajagopal, Rithwick — Washington University
- Study coordinator: Rajagopal, Rithwick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.